ReviewCurrent diabetes reports2015
Insights from cardiovascular outcome trials with novel antidiabetes agents: what have we learned? An industry perspective.
Boaz Hirshberg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it